| 2-mercaptobenzothiazole | Approved Vet Approved | CCL2 | 6347 |
downregulated | captax results in decreased expression of CCL2 mRNA | 17q12 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CCR2 | 729230 |
upregulated | captax results in increased expression of CCR2 mRNA | 3p21.31 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CCR5 | 1234 |
upregulated | captax results in increased expression of CCR5 mRNA | 3p21.31 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CREB1 | 1385 |
downregulated | captax results in decreased expression of CREB1 mRNA | 2q33.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CXCL1 | 2919 |
upregulated | captax results in increased expression of CXCL1 mRNA | 4q13.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CXCL8 | 3576 |
upregulated | captax results in increased expression of CXCL8 mRNA | 4q13.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | CYP1A1 | 1543 |
upregulated | captax results in increased expression of CYP1A1 mRNA | 15q24.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | DNAJB4 | 11080 |
upregulated | captax results in increased expression of DNAJB4 mRNA | 1p31.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | FTH1 | 2495 |
upregulated | captax results in increased expression of FTH1 mRNA | 11q12.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | FTL | 2512 |
upregulated | captax results in increased expression of FTL mRNA | 19q13.33 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | GCLC | 2729 |
upregulated | captax results in increased expression of GCLC mRNA | 6p12.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | GCLM | 2730 |
upregulated | captax results in increased expression of GCLM mRNA | 1p22.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | HMOX1 | 3162 |
upregulated | captax results in increased expression of HMOX1 mRNA | 22q12.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | HSPA6 | 3310 |
upregulated | captax results in increased expression of HSPA6 mRNA | 1q23.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | IL7R | 3575 |
upregulated | captax results in increased expression of IL7R mRNA | 5p13.2 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | MMP9 | 4318 |
upregulated | captax results in increased expression of MMP9 mRNA | 20q13.12 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | MYC | 4609 |
upregulated | captax results in increased expression of MYC mRNA | 8q24.21 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | NOTCH3 | 4854 |
downregulated | captax results in decreased expression of NOTCH3 mRNA | 19p13.12 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | NQO1 | 1728 |
upregulated | captax results in increased expression of NQO1 mRNA | 16q22.1 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | PMAIP1 | 5366 |
upregulated | captax results in increased expression of PMAIP1 mRNA | 18q21.32 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | RGS1 | 5996 |
upregulated | captax results in increased expression of RGS1 mRNA | 1q31.2 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | SEL1L3 | 23231 |
upregulated | captax results in increased expression of SEL1L3 mRNA | 4p15.2 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | SLC7A11 | 23657 |
upregulated | captax results in increased expression of SLC7A11 mRNA | 4q28.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | SQSTM1 | 8878 |
upregulated | captax results in increased expression of SQSTM1 mRNA | 5q35.3 | |
| 2-mercaptobenzothiazole | Approved Vet Approved | SYNE2 | 23224 |
downregulated | captax results in decreased expression of SYNE2 mRNA | 14q23.2 | |